Due to appetite suppression and slowed digestion and gastric emptying, it is common for people on GLP-1 medications to eat fewer meals, and thus fewer calories, than they did before
Retrieved from Papatriantafyllou, E., Efthymiou, D., Zoumbaneas, E., et al
Because of that, many plans choose to exclude weight-management drugs as a way to keep overall costs downeven when those medications are FDA-approved for chronic weight management
And while in most people with HIV traditional risk factors are driving their fatty liver disease, we do think there is a component of liver disease that is HIV specific, so some of those secondary effects of semaglutide may have unique benefits in people with HIV. Lake and colleagues enrolled 49 adults with MASLD and HIV into the open-label phase 2b SLIM LIVER study